VYGR – voyager therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer's Disease [Yahoo! Finance]
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $14.00 price target on the stock.
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Form SC 13G/A Voyager Therapeutics, Filed by: EcoR1 Capital, LLC
Form SC 13G/A Voyager Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
Form 10-Q Voyager Therapeutics, For: Sep 30
Form 8-K Voyager Therapeutics, For: Nov 12
Form 4 Voyager Therapeutics, For: Oct 02 Filed by: Fahey Sandell Jacquelyn
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.